Scott E. LeBlanc

805 total citations
13 papers, 635 citations indexed

About

Scott E. LeBlanc is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Scott E. LeBlanc has authored 13 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Oncology. Recurrent topics in Scott E. LeBlanc's work include Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (3 papers) and Signaling Pathways in Disease (2 papers). Scott E. LeBlanc is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (3 papers) and Signaling Pathways in Disease (2 papers). Scott E. LeBlanc collaborates with scholars based in United States, Italy and China. Scott E. LeBlanc's co-authors include John Svaren, Lawrence Wrabetz, R. Matthew Ward, Anthony N. Imbalzano, Sung‐Wook Jang, Qiong Wu, Saı̈d Sif, Sujatha Venkataraman, Randal S. Tibbetts and Angela M. Mabb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Scott E. LeBlanc

13 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott E. LeBlanc United States	13	452	188	84	70	67	13	635
Daniel Haag Germany	12	572 1.3×	141 0.8×	95 1.1×	107 1.5×	90 1.3×	15	791
Julio Aguila Benitez Sweden	9	492 1.1×	95 0.5×	90 1.1×	40 0.6×	76 1.1×	11	633
Isabelle Foucault France	10	492 1.1×	238 1.3×	45 0.5×	70 1.0×	54 0.8×	10	678
Melissa Hancock United States	8	377 0.8×	167 0.9×	98 1.2×	70 1.0×	37 0.6×	9	548
Carlos E. Pedraza United States	8	281 0.6×	151 0.8×	80 1.0×	38 0.5×	131 2.0×	11	513
Valérie Besset France	9	469 1.0×	261 1.4×	64 0.8×	101 1.4×	130 1.9×	11	799
Sandra Camelo United States	5	518 1.1×	111 0.6×	51 0.6×	47 0.7×	26 0.4×	6	771
Rod M. Feddersen United States	8	320 0.7×	124 0.7×	83 1.0×	85 1.2×	67 1.0×	10	436
Oleg Lioubinski Germany	7	329 0.7×	182 1.0×	41 0.5×	37 0.5×	116 1.7×	7	580
Vijay Swahari United States	12	547 1.2×	86 0.5×	231 2.8×	44 0.6×	69 1.0×	13	726

Countries citing papers authored by Scott E. LeBlanc

Since Specialization

Citations

This map shows the geographic impact of Scott E. LeBlanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. LeBlanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. LeBlanc more than expected).

Fields of papers citing papers by Scott E. LeBlanc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. LeBlanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. LeBlanc. The network helps show where Scott E. LeBlanc may publish in the future.

Co-authorship network of co-authors of Scott E. LeBlanc

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. LeBlanc. A scholar is included among the top collaborators of Scott E. LeBlanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. LeBlanc. Scott E. LeBlanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

LeBlanc, Scott E., et al.. (2016). Promoter–enhancer looping at the PPARγ2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucleic Acids Research. 44(11). 5133–5147. 30 indexed citations

Wu, Qiong, Hang Cui, Scott E. LeBlanc, et al.. (2016). Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells. Oncotarget. 7(19). 27158–27175. 43 indexed citations

LeBlanc, Scott E., Qiong Wu, A. Rasim Barutcu, et al.. (2014). The PPARγ Locus Makes Long-Range Chromatin Interactions with Selected Tissue-Specific Gene Loci during Adipocyte Differentiation in a Protein Kinase A Dependent Manner. PLoS ONE. 9(1). e86140–e86140. 13 indexed citations

LeBlanc, Scott E., Qiong Wu, Yujie Hu, et al.. (2012). Protein Arginine Methyltransferase 5 (Prmt5) Promotes Gene Expression of Peroxisome Proliferator-Activated Receptor γ2 (PPARγ2) and Its Target Genes during Adipogenesis. Molecular Endocrinology. 26(4). 583–597. 53 indexed citations

Xiao, Hengyi, Scott E. LeBlanc, Qiong Wu, et al.. (2010). Chromatin accessibility and transcription factor binding at the PPARγ2 promoter during adipogenesis is protein kinase A‐dependent. Journal of Cellular Physiology. 226(1). 86–93. 29 indexed citations

Marfella, Concetta G.A., Nils Henninger, Scott E. LeBlanc, et al.. (2008). A Mutation in the Mouse Chd2 Chromatin Remodeling Enzyme Results in a Complex Renal Phenotype. Kidney & Blood Pressure Research. 31(6). 421–432. 23 indexed citations

Nanjappa, Som G., Anju Singh, Erin H. Plisch, et al.. (2007). Cbl-b Regulates Antigen-Induced TCR Down-Regulation and IFN-γ Production by Effector CD8 T Cells without Affecting Functional Avidity. The Journal of Immunology. 179(11). 7233–7243. 38 indexed citations

LeBlanc, Scott E., R. Matthew Ward, & John Svaren. (2007). Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10. Molecular and Cellular Biology. 27(9). 3521–3529. 65 indexed citations

Jang, Sung‐Wook, Scott E. LeBlanc, Avtar Roopra, Lawrence Wrabetz, & John Svaren. (2006). In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. Journal of Neurochemistry. 98(5). 1678–1687. 58 indexed citations

10.

LeBlanc, Scott E., Sung‐Wook Jang, R. Matthew Ward, Lawrence Wrabetz, & John Svaren. (2005). Direct Regulation of Myelin Protein Zero Expression by the Egr2 Transactivator. Journal of Biological Chemistry. 281(9). 5453–5460. 83 indexed citations

11.

LeBlanc, Scott E., et al.. (2005). Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. Journal of Neurochemistry. 93(3). 737–748. 82 indexed citations

12.

Fu, Vivian, et al.. (2004). A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells. Journal of Biological Chemistry. 279(50). 52218–52226. 39 indexed citations

13.

Shi, Yuling, Sujatha Venkataraman, Gerald E. Dodson, et al.. (2004). Direct regulation of CREB transcriptional activity by ATM in response to genotoxic stress. Proceedings of the National Academy of Sciences. 101(16). 5898–5903. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact